相关实验视频

Updated: Jul 5, 2025

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

低风险妊娠 trofhoblastic瘤的第一线单药化疗:一个网络的元分析

Fang Zhou¹, Li Kemin^2,3

¹West China University Hospital of Sichuan University, Chengdu, Sichuan, China.

Frontiers in oncology

|January 22, 2024

概括

在一线单药化疗方案中,VP-16 (5天) 对低风险妊娠 trofhoblastic neoplasia (GTN) 的疗效是最高的. 对于随机对照试验 (RCT),ACT-D (5天) 显示出最佳疗效,尽管需要进一步验证.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
临床医学临床医学

背景情况:

第一线单一药物化疗是为低风险的妊娠热囊细胞瘤 (GTN) 建立的.
对个体GTN患者的最佳治疗方案选择仍然不确定.
孕期 trofhoblastic瘤 (GTN) 需要有效和个性化的治疗策略.

研究的目的:

评估和比较各种一线单药化疗方案对低风险GTN的疗效.
确定治疗低风险GTN的最有效的化疗方案.
为GTN治疗选择提供基于证据的指导.

主要方法:

在PubMed,Embase,Web of Science和Cochrane图书馆进行了系统的文献搜索,截至2022年11月.
网络元分析被用来比较六种不同的单药化疗方案的完整反应率.
分析了24项研究,包括9项RCT和15项非RCT,涉及3344名患者.

主要成果:

在所有研究的总体分析中,VP-16 (5天) 显示出最高的疗效.
在随机对照试验 (RCT) 中,ACT-D (5天) 显示出最佳的疗效.
分析的治疗方案,按照疗效的下降顺序,是VP-16 (5天),ACT-D (5天),MTX (5天),ACT-D (1.25毫克/米2),MTX (8天) 和MTX (30-50毫克/米2).

结论:

根据综合数据,VP-16 (5天) 是对低风险GTN的最有效的第一线单一药物化疗.
ACT-D (5天) 成为RCT中领先的治疗方案,表明其在更高质量的证据中的潜力.
建议进一步进行高质量的临床研究,以验证这些发现,并完善GTN的治疗指南.

关键词:

在GTN GTN中.第一线化疗的第一线化疗.低风险的妊娠 trofhoblastic 瘤.这是一种单一药物.网络元分析网络元分析

更多相关视频

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...